Status:
RECRUITING
Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Acute Ovarian Failure
Infertility
Eligibility:
FEMALE
4-35 years
Brief Summary
Background: Medical advances have improved survival rates for many cancers and other illnesses. This means that more people are coping with the long-term effects of these treatments. Some treatments ...
Detailed Description
Study Description: We will provide ovarian tissue cryopreservation (OTC) as a clinical service at NIH and collect a portion of the tissue for research regarding normal histology and function of the h...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Provision of signed and dated informed consent/assent form.
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Subjects who have planned to undergo OTC for gonadotoxic therapy based on current standard of care.
- EXCLUSION CRITERIA:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- -Adults subjects with psychological, psychiatric, or other conditions which prevent giving fully informed consent.
Exclusion
Key Trial Info
Start Date :
July 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 21 2041
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05440617
Start Date
July 22 2022
End Date
September 21 2041
Last Update
January 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892